Form 4 for PHVS Pharvaris N.V.
Accepted 2026-05-19 18:48:21 ET · period of report 2026-05-15 · accession 0001193125-26-231291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-19 18:48 | 2026-05-15 | PHVS | Glassman Robert | Dir | M - OptEx | $22.31 | +5,333 | 20.5K | +35% | +$119.0K |
| DM | 2026-05-19 18:48 | 2026-05-15 | PHVS | Glassman Robert | Dir | S - Sale+OE | $29.82 | -10.0K | 10.5K | -49% | -$298.2K |
| D | 2026-05-19 18:48 | 2026-05-15 | PHVS | Glassman Robert | Dir | M - OptEx | $0.00 | -5,333 | 8,667 | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | M | A | 5,333 | $22.31 | 20,500 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-15 | S | D | 5,333 | $29.83 | 15,167 | D | — | — | (F1) The reported price represents a weighted sale price for shares sold in multiple transactions on the reported date. The shares reported herein include shares of common stock acquired upon vestring of restricted stock units on various dates. The sales prices for the transactions ranged from $29.6550 to $29.92. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-05-15 | S | D | 4,667 | $29.82 | 10,500 | D | — | — | (F2) The reported price represents a weighted sale price for shares sold in multiple transactions on the reported date. The shares reported herein include shares of common stock acquired upon vestring of restricted stock units on various dates. The sales prices for the transactions ranged from $29.7750 to $29.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-05-15 | M | D | 5,333 | $0.00 | 8,667 | D | $22.31 · 2026-05-15 to 2034-04-11 | 5,333 Common Stock | (F3) 100% of the option vested on anniversary of grant, April 11th, 2025. |